{
  "company": {
    "name": "Ancilia Bio",
    "website": "https://anciliabio.com/",
    "record": "https://startuphistory.org/c/anciliabio.com"
  },
  "status": null,
  "history_since": "2021-12-08T23:36:24.000Z",
  "baseline": {
    "snapshot_id": "9cc58cf051741b36cd9972bb74cc941905c37bfae7d3dee0ef14288ce7e320b3",
    "observed_at": "2021-12-08T23:36:24.000Z",
    "headline": "Ancilia Biosciences",
    "description": null,
    "evidence": "https://web.archive.org/web/20211208233624/https://www.anciliabio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-04T11:29:33.877Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2023-10-07T21:03:46.000Z",
      "variants": [
        {
          "headline": "Ancilia Biosciences",
          "subhead": null,
          "observed_at": "2021-12-08T23:36:24.000Z",
          "evidence": "https://web.archive.org/web/20211208233624/https://www.anciliabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Ancilia Biosciences",
          "subhead": null,
          "observed_at": "2022-07-15T16:46:53.000Z",
          "evidence": "https://web.archive.org/web/20220715164653/https://www.anciliabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Ancilia Biosciences",
          "subhead": "A CRISPR route to success for live biotherapeutics & bacterial products",
          "observed_at": "2023-05-08T20:44:07.000Z",
          "evidence": "https://web.archive.org/web/20230508204407/https://www.anciliabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Ancilia Biosciences",
          "subhead": "A CRISPR route to success for live biotherapeutics & bacterial products",
          "observed_at": "2023-10-07T21:03:46.000Z",
          "evidence": "https://web.archive.org/web/20231007210346/https://www.anciliabio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Ancilia Biosciences",
      "subhead": "A CRISPR route to success for live biotherapeutics & bacterial products",
      "from": "2021-12-08T23:36:24.000Z",
      "to": "2023-10-07T21:03:46.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20231007210346/https://www.anciliabio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-12-08T23:36:24.000Z",
          "to": "2023-10-07T21:03:46.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-04T11:29:33.877Z",
      "variants": [
        {
          "headline": "CRISPR-mediated viral immunity",
          "subhead": "CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia",
          "observed_at": "2024-06-12T18:05:22.000Z",
          "evidence": "https://web.archive.org/web/20240612180522/https://www.anciliabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "CRISPR-mediated viral immunity",
          "subhead": "CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia",
          "observed_at": "2024-07-20T16:18:18.000Z",
          "evidence": "https://web.archive.org/web/20240720161818/https://www.anciliabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "CRISPR-mediated viral immunity",
          "subhead": "CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia",
          "observed_at": "2025-01-15T05:34:04.000Z",
          "evidence": "https://web.archive.org/web/20250115053404/https://www.anciliabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "CRISPR-mediated viral immunity",
          "subhead": "CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia",
          "observed_at": "2025-07-12T16:39:20.000Z",
          "evidence": "https://web.archive.org/web/20250712163920/https://www.anciliabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "CRISPR-mediated viral immunity",
          "subhead": "CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia",
          "observed_at": "2026-01-16T12:40:06.000Z",
          "evidence": "https://web.archive.org/web/20260116124006/https://www.anciliabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "CRISPR-mediated viral immunity",
          "subhead": "CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia",
          "observed_at": "2026-07-07T18:19:00.000Z",
          "evidence": "https://web.archive.org/web/20260707181900/https://www.anciliabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "CRISPR-mediated viral immunity",
          "subhead": "CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia",
          "observed_at": "2026-11-04T11:29:33.877Z",
          "evidence": "https://www.anciliabio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "CRISPR-mediated viral immunity",
      "subhead": "CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia",
      "from": "2024-06-12T18:05:22.000Z",
      "to": "2026-11-04T11:29:33.877Z",
      "captures": 7,
      "evidence": "https://www.anciliabio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2024-06-12T18:05:22.000Z",
          "to": "2026-11-04T11:29:33.877Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Ancilia Bio” company record, https://startuphistory.org/c/anciliabio.com"
}